Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference Transcript

May 31, 2023 / 02:00PM GMT
Lee Michael Hambright - Sanford C. Bernstein & Co., LLC., Research Division - Analyst

Okay. We are live. Great. Thank you. So hi everybody, I'm Lee Hambright, U.S. medical device analyst at Bernstein. We are thrilled to host Johnson & Johnson, Chairman and CEO, Joaquin Duato. Thanks so much for being here. We're scheduled for a 50-minute fireside chat. Just a reminder that you can submit questions through pigeon hole at any time.

Joaquin, thanks so much for being here. It's been 1.5 years since you stepped into the CEO role. Maybe you could just start by reflecting a little bit on your experiences and talking about the state of the business at J&J.

Joaquin Duato - Johnson & Johnson - CEO & Chairman

Thank you, and thank you for coming to listen to this fireside chat. So let's start with the first quarter and see how Johnson & Johnson has been doing. We had a good first quarter with adjusted (added by company after the call) operational growth for Johnson & Johnson of over (added by company after the call) 7.5%, which you have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot